The Southeastern Pennsylvania Transportation Authority (“SEPTA”) and Teamsters Local 710, co-lead plaintiffs in the Abbott Laboratories shareholder derivative case, filed a comprehensive amended complaint on October 16, 2023. The amended complaint presents detailed allegations addressing claims related to Abbott’s production and sale of infant formula products.​

The amended complaint asserts that Abbott officers and directors breached fiduciary duties by concealing safety protocol lapses at the Sturgis facility, leading to environmental contamination with Cronobacter sakazakii bacteria.  Following a February 2022 FDA inspection confirming Cronobacter contamination, Abbott issued a recall of various infant formula products, impacting the U.S., Canada, and other markets. The amended complaint alleges that Abbott portrayed the recall as proactive, concealing the FDA investigation.​

The closure of the Sturgis facility, due to safety concerns, resulted in massive formula shortages in the U.S., prompting the federal government to invoke the Defense Production Act to address the crisis.  Further, the amended complaint references a whistleblower complaint, publicly disclosed in April 2022, alleging Abbott management’s awareness of issues at the Sturgis facility, including false test records, releasing untested infant formula, and attempts to mislead the FDA.​

John A. Kehoe, Partner at Kehoe Law Firm, commented on the strength of the amended complaint: “The detailed amended complaint filed by SEPTA and Teamsters Local 710 underscores the gravity of the allegations against Abbott. The document meticulously outlines breaches of fiduciary duties, concealment of safety issues, and the subsequent impact on the market. We believe these allegations are robust and compelling, reflecting our commitment to pursuing justice for shareholders and ensuring corporate accountability.”​

The filing of the amended complaint marks a significant milestone in the Abbott shareholder derivative case. Kehoe Law Firm remains dedicated to representing institutional investors in cases that uphold shareholder rights and seek to improve corporate governance.

For more information about Kehoe Law Firm and its involvement in this matter, please contact John A. Kehoe at [email protected] or call (215) 792-6676.

The Kehoe Law Firm is proud to announce that its client, the Policemen’s Annuity and Benefit Fund of Chicago (“PABF”), court-appointed lead plaintiff in the Twist Bioscience Corporation securities class action, has taken a significant step forward in the pursuit of justice. On October 11, 2023, PABF filed an amended complaint in the ongoing litigation against Twist Bioscience Corporation.​

John Kehoe, Partner with the Kehoe Law Firm, commented on the filing, saying, “Our client, the Policemen’s Annuity and Benefit Fund of Chicago, remains steadfast in its commitment to seeking justice on behalf of the class of investors. The filing of the amended complaint is a crucial step in the legal process, allowing us to present a more comprehensive case that reflects the latest developments and information relevant to the securities class action against Twist Bioscience Corporation.”​

The securities class action alleges that Twist Bioscience Corporation, a biotechnology company specializing in synthetic DNA and DNA products, made false and misleading statements regarding its growth prospects and financial health. The amended complaint provides additional context and evidence supporting the claims made by PABF and the proposed class of investors.​

The Kehoe Law Firm continues to work diligently to represent the interests of PABF and the class, leveraging its experience and expertise in securities litigation to hold Twist Bioscience Corporation accountable for alleged securities law violations.​

The complaint is pending in the U.S. District Court for the Northern District of California and captioned, Peters v. Twist Bioscience Corp., et. al., 5:22-CV-8168. 

For more information about Kehoe Law Firm and its involvement in this matter, please contact John A. Kehoe at [email protected] or call (215) 792-6676.

In a significant development, the United States District Court for the Northern District of Illinois Eastern Division issued an order consolidating multiple Abbott shareholder derivative cases, with the Teamsters Local 710 Pension Fund and Southeastern Pennsylvania Transportation Authority (SEPTA) appointed as co-lead plaintiffs. Kehoe Law Firm, representing institutional investors, welcomes this decision, emphasizing the importance of streamlined proceedings to address allegations related to Abbott Laboratories. 

The order, issued by Judge Manish S. Shah on September 18, 2023, grants the motion to consolidate cases and appoint co-lead plaintiffs, filed by the Teamsters Local 710 Pension Fund and SEPTA. The court also denied competing motions from other plaintiffs, including New York State Comptroller Thomas P. DiNapoli, as Trustee of the New York State Common Retirement Fund.  

The action concerns whether the Individual Defendants concealed lapses in safety protocols at Abbott’s Sturgis, Michigan facility, and thereby breached their fiduciary duties and violated federal securities laws. The alleged lapses resulted in environmental contamination with Cronobacter sakazakii bacteria, a critical issue affecting the manufacturing of Abbott’s infant formula and leading to a notional shortage. 

John A. Kehoe, Partner at Kehoe Law Firm, expressed his satisfaction with the court’s decision: “We are pleased with the court’s order to consolidate the Abbott shareholder derivative cases, bringing efficiency and focus to the legal proceedings. The appointment of SEPTA the Teamsters Local 710 Pension Fund as co-lead plaintiffs underscores the court’s confidence in their ability to represent shareholder interests effectively. At Kehoe Law Firm, we remain committed to representing investors in cases that contribute to corporate governance accountability and protect shareholder value.” 

The court’s decision acknowledges the competence of all parties involved, highlighting the dedication of SEPTA and Teamsters Local 710, along with their chosen counsel, in navigating the complexities of the case. The consolidated action is captioned, In Re Abbott Laboratories Infant Formula Shareholder Derivative Litigation, 22-CV-5513 (N.D. IL).​

For more information about Kehoe Law Firm and its involvement in this matter, please contact John A. Kehoe at [email protected] or call (215) 792-6676.

Investor Michael D. Levine, a shareholder of grill maker Weber Inc. before its acquisition by BDT Capital Partners LLC, has filed a lawsuit in Delaware Chancery Court seeking access to company documents. The legal action aims to investigate potential breaches of fiduciary duty by Weber Inc.’s officers and directors in connection with the take-private transaction.​

Weber Inc. announced in December 2022 that it would be acquired by investment funds managed by BDT Capital Partners in a take-private transaction valued at $8.05 per share, with a total enterprise value of $3.7 billion. The deal closed in February 2023, leading to the delisting of Weber’s stock from the New York Stock Exchange.​

Levine’s complaint, filed under seal on Wednesday, outlines concerns and allegations regarding the transaction. According to Levine, the $8.05 deal price represents a substantial discount from the $14 per share paid by stockholders in Weber’s initial public offering in August 2021.

The lawsuit asserts that the timing of the transaction was designed to “squeeze out public stockholders” during a period of temporary stock price depression. Levine claims that an avoidable liquidity crunch hampered the special committee formed to negotiate the deal.​

The complaint also alleges that BDT approved the deal through written consent, giving minority stockholders no say in the price and no ability to veto a potentially unfavorable deal.  Levine sent an inspection demand letter to Weber in January under Section 220 of Delaware General Corporation Law, seeking access to corporate books and records for investigating suspected corporate wrongdoing. While the company produced three rounds of documents, Levine contends that they were insufficient and failed to provide a clear record of the board and special committee’s relevant deliberations. Many of the records were heavily redacted, concealing crucial financial and operational information.

Commenting on the lawsuit, Partner Michael Yarnoff stated, “The transaction does not appear fair to public stockholders and may have resulted from breaches of fiduciary duty by the officers and directors of the company.”

For more information about Kehoe Law Firm and its involvement in this matter, please contact Michael Yarnoff at [email protected] or call (215) 792-6676.

Kehoe Law Firm, a leading advocate for workers’ rights, expresses its deep satisfaction and gratitude for the backing received from the U.S. Department of Justice (DOJ) and 21 state-level enforcers in the ongoing appeal before the Second Circuit.  The case involves former Saks Fifth Avenue employees who allege the retailer engaged in no-hire agreements, suppressing their wages and restricting job mobility.

The DOJ and the states filed separate amicus briefs on Friday, contesting the lower court’s dismissal earlier this year. The DOJ argued that the court incorrectly applied the ancillary restraints doctrine, emphasizing that the no-hire agreements were not merely “ancillary”, but the primary objective of a conspiracy aimed at reducing workers’ compensation and mobility.

Michael Yarnoff, a partner at Kehoe Law Firm, expressed his appreciation for the growing support in the case: “We are pleased to see the U.S. Department of Justice and the states recognize the significance of this matter. Their involvement underscores the importance of challenging anti-worker and anti-competitive practices in the labor market.”

The case, initiated by workers Susan Giordano, Angelene Hayes, Ying-Liang Wang, and Anja Beachum in February 2020, alleges that Saks prevented them from working at luxury retail stores owned by Gucci, Louis Vuitton, Prada, Brunello Cucinelli, and Loro Piana. The workers contend that these no-hire pacts violate antitrust laws, leading to lower wages and restricted mobility.

The lower court’s dismissal in February prompted an appeal to the Second Circuit. The DOJ’s recent brief not only challenges the per se finding but also disputes the lower court’s ruling on the timeliness of claims for three workers, asserting that they were “undercompensated by Saks during the entirety of their tenures.”

Michael Yarnoff expressed satisfaction with the additional support: “The antitrust issues surrounding the alleged no-hire agreement are important, not just in this case, but to workers more generally. We look forward to winning in the appellate court and then ultimately vindicating our clients rights and interests in front of a jury in Brooklyn.” Kehoe Law Firm remains committed to advocating for the rights of workers and will continue to pursue justice for its clients in this crucial appeal.​

For more information about Kehoe Law Firm and its involvement in this matter, please contact Michael Yarnoff at [email protected] or call (215) 792-6676.

The Kehoe Law Firm, a national securities litigation law firm, is pleased to announce that its client, the Policemen’s Annuity and Benefit Fund of Chicago (“PABF”), has been appointed as the lead plaintiff in the securities class action against Twist Bioscience Corporation. The United States District Court for the Northern District of California has granted PABF’s Motion for Appointment as Lead Plaintiff and Approval of its Selection of Lead Counsel.​

This decision comes after a thorough review of several motions to appoint lead plaintiff and select lead counsel in the securities class action governed by the Private Securities Litigation Reform Act of 1995 (“PSLRA”). Among the competing motions, PABF emerged as the lead plaintiff, showcasing its strong position in the litigation. 

John Kehoe, Partner with the Kehoe Law Firm, expressed his satisfaction with the court’s decision, stating, “We are very pleased that our client, the Policemen’s Annuity and Benefit Fund of Chicago, has been chosen to lead this important securities class action litigation. This decision reflects the confidence the court has in our client’s ability to effectively represent the class and pursue justice in this matter.” 

The securities class action alleges that Twist Bioscience Corporation, a biotechnology company specializing in synthetic DNA and DNA products, misled investors about its growth prospects and financial health. The complaint contends that between December 13, 2019, and November 14, 2022, Twist, along with its executives, assured investors of substantial growth, only to face significant setbacks following the release of a critical report by Scorpion Capital.

Scorpion Capital’s report, published on November 15, 2022, raised concerns about Twist’s financial sustainability, likening its DNA chip technology to the infamous Theranos scandal. Following the report, Twist’s stock price experienced a sharp decline, leading to substantial losses for investors. 

PABF’s lead plaintiff appointment underscores the Kehoe Law Firm’s dedication to representing the interests of investors and holding corporations accountable for alleged securities law violations. The firm is committed to working diligently on behalf of its client and the class to pursue a favorable resolution in this litigation.

For more information about Kehoe Law Firm and its involvement in this matter, please contact John A. Kehoe at [email protected] or call (215) 792-6676.